PP
IMGN

PDT Partners’s Immunogen Inc IMGN Stock Holding History

PDT Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-330,700
Closed -$2.13M – 910
2020
Q4 		$2.13M Sell
330,700
-17,600
-5% -$103K 0.14% 243
2020
Q3 		$1.25M Hold
348,300
– – 0.08% 268
2020
Q2 		$1.6M Sell
348,300
-70,400
-17% -$299K 0.11% 226
2020
Q1 		$1.43M Buy
418,700
+241,871
+137% +$1.06M 0.11% 189
2019
Q4 		$903K Buy
+176,829
New +$600K 0.06% 300
2016
Q2 		– Sell
-127,900
Closed -$1.09M – 585
2016
Q1 		$1.09M Buy
127,900
+1,100
+0.9% +$9.31K 0.07% 301
2015
Q4 		$1.72M Sell
126,800
-784
-0.6% -$9.65K 0.24% 158
2015
Q3 		$1.23M Buy
+127,584
New +$1.87M 0.03% 657
2015
Q2 		– Sell
-73,097
Closed -$654K – 1703
2015
Q1 		$654K Buy
+73,097
New +$529K 0.02% 924
2014
Q4 		– Sell
-13,500
Closed -$143K – 1164
2014
Q3 		$143K Buy
+13,500
New +$153K ﹤0.01% 1218
2014
Q2 		– Sell
-60,769
Closed -$907K – 1697
2014
Q1 		$907K Buy
+60,769
New +$958K 0.02% 710
2013
Q4 		– Sell
-12,064
Closed -$205K – 1238
2013
Q3 		$205K Buy
+12,064
New +$212K 0.01% 1390

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PDT Partners's IMGN Position: Q1 2021 in Review

PDT Partners sold out of Immunogen Inc (IMGN) in Q1 2021, closing a stake of 330,700 shares — an estimated $2.13M sold.

PDT Partners first reported a position in IMGN in Q3 2013 and held it in 12 quarters. The position peaked at $2.13M in Q4 2020. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2021.

  • PDT Partners reported no remaining Immunogen Inc position as of Q1 2021 after selling out during the quarter.
  • PDT Partners sold 330,700 Immunogen Inc shares in Q1 2021, an estimated $2.13M.
  • PDT Partners first reported a position in Immunogen Inc in Q3 2013 and held it in 12 quarters.
  • PDT Partners's Immunogen Inc position peaked at $2.13M in Q4 2020.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2021.

Based on PDT Partners's 13F filing for Q1 2021, filed 17 May 2021.